
The new industry deals progressing drug discovery
New partnerships, acquisitions and collaborations are helping drug discovery companies to tackle some of the biggest problems facing the industry. These include patient access to cell and gene therapies, the development of DNA gene therapies, and the challenges surrounding GI clinical trials. Delbert acquires injectable antibiotic from Bristol Myers Squibb… Read More














